JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TNXP - Tonix Pharmaceuticals Holding Corp.
USD | NASDAQ | Healthcare
Summary
Summary TNXP Stock
Financials
Financials TNXP Stock
Loading...
Loading...
Income Statement
Income Statement TNXP Stock
Balance Sheet
Balance Sheet TNXP Stock
Cash Flow Statement
Cash Flow Statement TNXP Stock
Loading...
Loading...
Home
Stocks
Tonix Pharmaceuticals Holding Corp. (TNXP)
Financials
Financials of TNXP
Loading...
Loading...
Loading...
Loading...
TNXP Financials - Tonix Pharmaceuticals Holding Income & Cash Flow | Ledgeburg
Revenue
$13.107M
Operating Income
$-125.703M
Net Income
$-124.021M
Share Count (Basic)
8.511318M
Operating Cash Flow
$-99.844M
Free Cash Flow
$-103.213M
Cash And Short-Term Equivalents
$207.637M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
5M
10M
FY2023
FY2024
FY2025
Revenue $USD
0
2M
4M
6M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-130M
-120M
-110M
-100M
-90M
Annual
Quarterly
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-50M
-40M
-30M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26